REQUEST A DEMO
Total
USD $0.00
Search more companies

Fresenius Kabi Colombia S A S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Fresenius Kabi Colombia S A S Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Fresenius Kabi Colombia S A S is based in Colombia. The head office is in Bogota D.C.. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on December 17, 2010. 218 (2024) employees currently work for Fresenius Kabi Colombia S A S. In 2023, the company reported a net sales revenue increase of 17.67%. A growth of 6.75% was recorded in its total assets.

Headquarters
Av Cr 7 155 C 20 Ed North Point To E P 40
Bogota D.C.; Bogota D.C; Postal Code: 1007

Contact Details: Purchase the Fresenius Kabi Colombia S A S report to view the information.

Basic Information
Total Employees:
Purchase the Fresenius Kabi Colombia S A S report to view the information.
Outstanding Shares:
Purchase the Fresenius Kabi Colombia S A S report to view the information.
Incorporation Date:
December 17, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Fresenius Kabi Colombia S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
17.67%
Total operating revenue
17.67%
Operating profit (EBIT)
437.06%
EBITDA
129.49%
Net Profit (Loss) for the Period
N/A
Total assets
6.75%
Total equity
16.37%
Operating Profit Margin (ROS)
6.18%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
17.21%
Quick Ratio
0.21%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?